Default: International Journal of Rheumatology

ISSN: 1687-9260

Journal Home

Journal Guideline

International Journal of Rheumatology Q3 Unclaimed

Hindawi Publishing Corporation United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Rheumatology is a journal indexed in SJR in Immunology and Rheumatology with an H index of 40. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 922,5 €. The scope of the journal is focused on rheumatology, arthritis. It has an SJR impact factor of 0,644 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,644.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

922,5 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Journal of Rheumatology

0,644

SJR Impact factor

40

H Index

4

Total Docs (Last Year)

29

Total Docs (3 years)

217

Total Refs

66

Total Cites (3 years)

29

Citable Docs (3 years)

2.15

Cites/Doc (2 years)

54.25

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?

View more

IgG4-Related Lymphadenopathy

View more

IgG4-Related Perineural Disease

View more

Apoptosis Modulation as a Promising Target for Treatment of Systemic Sclerosis

View more

Review of Current Immunologic Therapies for Hidradenitis Suppurativa

View more

Biologicals

View more

Necrotizing Lymphocytic Vasculitis Limited to the Peripheral Nerves: Report of Six Cases and Review

View more

Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment

View more

Pain Mystery Score Beliefs: A Comparison of Fibromyalgia and Rheumatoid Arthritis

View more

Gastrointestinal Symptoms and Elevated Levels of Anti-Saccharomyces cerevisiae Antibodies Are Associated with Higher Disease Activity in Colombian Patients with Spondyloarthritis

View more

Biologic Agents - A Panacea for Inflammatory Arthritis or Not?

View more

Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation

View more
SHOW MORE ARTICLES

The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis

View more

Digital Ischemic Loss in Systemic Sclerosis

View more

Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO)

View more

Detailed Joint Region Analysis of the 7-Joint Ultrasound Score: Evaluation of an Arthritis Patient Cohort over One Year

View more

Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood

View more

Behcet's Disease: Is There Geographical Variation? A Review Far from the Silk Road

View more

Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease

View more

Parotid Gland Biopsy as an Additional Diagnostic Tool for Supporting the Diagnosis of Sjogren's Syndrome

View more

Efficacy of Vitamin E in Methotrexate-Induced Hepatotoxicity in Rheumatoid Arthritis: An Open-Label Case-Control Study

View more

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac

View more

Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy

View more

Type 1 Autoimmune Pancreatitis Can Transform into Chronic Pancreatitis: A Long-Term Follow-Up Study of 73 Japanese Patients

View more

FAQS